OssDsign AB Celebrates 10,000 US Patients Treated with Breakthrough Bone Regeneration Device
OssDsign AB has reached a significant milestone, treating 10,000 patients in the US with its innovative bone regeneration product, OssDsign Catalyst.
2 minutes to read